FRZB and neoplasm: The tRNAiMet secretome contains a number of pro-tumorigenic growth factors (such as frizzled-related protein and TGF-β2), and we are currently considering the possibility that type II collagen production is associated with secretion of these growth factors and their incorporation into the ECM, increasing their presentation to tumor and endothelial cells.